{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T17:09:15Z","timestamp":1693674555126},"reference-count":257,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,3,16]]},"abstract":"<jats:sec>\n<jats:title \/>\n<jats:p>Neglected Tropical Diseases (NTDs) form a group of diseases that are strongly associated\nwith poverty, flourish in impoverished environments, and thrive best in tropical areas,\nwhere they tend to present overlap. They comprise several diseases, and the symptoms\nvary dramatically from disease to disease, often causing from extreme pain, and untold misery\nthat anchors populations to poverty, permanent disability, and death. They affect more than 1\nbillion people worldwide; mostly in poor populations living in tropical and subtropical climates.\nIn this review, several complementary in silico approaches are presented; including\nidentification of new therapeutic targets, novel mechanisms of activity, high-throughput\nscreening of small-molecule libraries, as well as in silico quantitative structure-activity relationship\nand recent molecular docking studies. Current and active research against Sleeping\nSickness, American trypanosomiasis, Leishmaniasis and Schistosomiasis infections will hopefully\nlead to safer, more effective, less costly and more widely available treatments against\nthese parasitic forms of Neglected Tropical Diseases (NTDs) in the near future.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867326666190711121418","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T09:14:29Z","timestamp":1562922869000},"page":"795-834","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recent Theoretical Studies Concerning Important Tropical Infections"],"prefix":"10.2174","volume":"27","author":[{"given":"Marcus Tullius","family":"Scotti","sequence":"first","affiliation":[{"name":"Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Para\u00edba, Joao Pessoa - PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex France Messias","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Para\u00edba, Joao Pessoa - PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssika","family":"de Oliveira Viana","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Para\u00edba, Joao Pessoa - PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Jaime","family":"Bezerra Mendon\u00e7a Junior","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Para\u00edba, Joao Pessoa - PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamilton M.","family":"Ishiki","sequence":"additional","affiliation":[{"name":"University of Western Sao Paulo (Unoeste), Presidente Prudente, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernestine Nkwengoua","family":"Tchouboun","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Science, University of Yaounde IPO Box 812, Yaounde, Cameroon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Santos A.","family":"De Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Laboratory of Synthesis and Drug Delivery, Department of Biological Science, State University of Paraiba, Joao Pessoa, PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Scotti","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Para\u00edba, Joao Pessoa - PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","year":"2010","unstructured":"Control of the Leishmaniasis, Genebra, Suica WHO - World Health Organization(Accessed: January 15, 2018).2010","journal-title":"Control of the Leishmaniasis, Genebra, Suica"},{"key":"ref=2","year":"2012","unstructured":"WHO - World Health Organization. WHO Global Malaria\nProgramme. World Malaria Report, Geneva, Switzerland Available at:(Accessed: January\n15, 2018).2012","journal-title":"World Malaria Report, Geneva, Switzerland"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"E506","DOI":"10.1073\/pnas.1717806115","volume":"115","author":"Grybchuk D.","year":"2018","unstructured":"Grybchuk D.; Akopyants N.S.; Kostygov A.Y.; Konovalovas A.; Lye L.F.; Dobson D.E.; Zangger H.; Fasel N.; Butenko A.; Frolov A.O.; Vot\u00fdpka J.; d\u2019Avila-Levy C.M.; Kulich P.; Moravcov\u00e1 J.; Plevka P.; Rogozin I.B.; Serva S.; Luke\u0161 J.; Beverley S.M.; Yurchenko V.; Viral discovery and diversity in trypanosomatid protozoa with a focus on relatives of the human parasite Leishmania. Proc Natl Acad Sci USA 2018,115(3),E506-E515","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=4","unstructured":"WHO(Accessed: February 14, 2018)."},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exppara.2013.11.003","volume":"136","author":"de Mello T.F.","year":"2014","unstructured":"de Mello T.F.; Bitencourt H.R.; Pedroso R.B.; Aristides S.M.; Lonardoni M.V.C.; Silveira T.G.V.; Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis. Exp Parasitol 2014,136,27-34","journal-title":"Exp Parasitol"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946201759091","volume":"59","author":"Gosch C.S.","year":"2017","unstructured":"Gosch C.S.; Marques C.P.; Resende B.S.; Souza J.D.S.; Rocha R.A.D.S.; Lopes D.S.S.; Gosch M.S.; Dias F.R.; Dorta M.L.; American tegumentary leishmaniasis: epidemiological and molecular characterization of prevalent Leishmania species in the State of Tocantins, Brazil, 2011-2015. Rev Inst Med Trop S\u00e3o Paulo 2017,59","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.foodchem.2013.05.025","volume":"141","author":"Manjolin L.C.","year":"2013","unstructured":"Manjolin L.C.; dos Reis M.B.; Maquiaveli, Cdo.C.; Santos-Filho, O.A.; da Silva, E.R. Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection. Food Chem 2013,141(3),2253-2262","journal-title":"Food Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jcb.24654","volume":"115","author":"Keller A.A.","year":"2014","unstructured":"Keller A.A.; Breitling R.; Hemmerich P.; Kappe K.; Braun M.; Wittig B.; Schaefer B.; Lorkowski S.; Reissmann S.; Transduction of proteins into leishmania tarentolae by formation of non-covalent complexes with cell-penetrating peptides. J Cell Biochem 2014,115(2),243-252","journal-title":"J Cell Biochem"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/673058","volume":"2013","author":"da Silva S.S.","year":"2013","unstructured":"da Silva S.S.; Thom\u00e9, Gda.S.; Cataneo, A.H.D.; Miranda, M.M.; Felipe, I.; Andrade, C.G.T.D.; Watanabe, M.A.E.; Piana, G.M.; Sforcin, J.M.; Pavanelli, W.R.; Conchon-Costa, I. Brazilian propolis antileishmanial and immunomodulatory effects. Evid Based Complement Alternat Med 2013,2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1017\/S0031182009991405","volume":"137","author":"Gomes D.C.O.","year":"2010","unstructured":"Gomes D.C.O.; Muzitano M.F.; Costa S.S.; Rossi-Bergmann B.; Effectiveness of the immunomodulatory extract of Kalanchoe pinnata against murine visceral leishmaniasis. Parasitology 2010,137(4),613-618","journal-title":"Parasitology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s00044-011-9647-8","volume":"21","author":"Syed U.F.R.","year":"2012","unstructured":"Syed U.F.R.; Hamid L.S.; Muhammad N.A.; Matloob A.; Mujahid H.B.; Novel quinolyl-thienylchalcones and their 2-pyrazoline derivatives with diverse substitution pattern as antileishmanial agents against Leishmania major. Med Chem Res 2012,21(7),1322-1333","journal-title":"Med Chem Res"},{"key":"ref=12","unstructured":"Diseases  Drugs for Neglected Diseases Initiative(Accessed: January\n15, 2018).","journal-title":"Diseases"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.3390\/molecules15107363","volume":"15","author":"Scotti L.","year":"2010","unstructured":"Scotti L.; Ferreira E.I.; Silva M.S.; Scotti M.T.; Chemometric studies on natural products as potential inhibitors of the NADH oxidase from Trypanosoma cruzi using the VolSurf approach. Molecules 2010,15(10),7363-7377","journal-title":"Molecules"},{"key":"ref=14","unstructured":"Chagas disease (American trypanosomiasis), Available\nat: WHO (Accessed: March 23, 2018).","journal-title":"Chagas disease (American trypanosomiasis), Available\nat:"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/MMBR.44.1.140-173.1980","volume":"44","author":"McGhee R.B.","year":"1980","unstructured":"McGhee R.B.; Cosgrove W.B.; Biology and physiology of the lower Trypanosomatidae. Microbiol Rev 1980,44(1),140-173","journal-title":"Microbiol Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"7761","DOI":"10.3390\/molecules18077761","volume":"18","author":"Ogungbe I.V.","year":"2013","unstructured":"Ogungbe I.V.; Setzer W.N.; \n                        In-silico Leishmania target selectivity of antiparasitic terpenoids. Molecules 2013,18(7),7761-7847","journal-title":"Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpddr.2013.10.001","volume":"4","author":"Pham J.S.","year":"2013","unstructured":"Pham J.S.; Dawson K.L.; Jackson K.E.; Lim E.E.; Pasaje C.F.A.; Turner K.E.C.; Ralph S.A.; Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites. Int J Parasitol Drugs Drug Resist 2013,4(1),1-13","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/138161207780162809","volume":"13","author":"L\u00fcscher A.","year":"2007","unstructured":"L\u00fcscher A.; de Koning H.P.; M\u00e4ser P.; Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting. Curr Pharm Des 2007,13(6),555-567","journal-title":"Curr Pharm Des"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/tmi.12483","volume":"20","author":"Steinmann P.","year":"2015","unstructured":"Steinmann P.; Stone C.M.; Sutherland C.S.; Tanner M.; Tediosi F.; Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review. Trop Med Int Health 2015,20(6),707-718","journal-title":"Trop Med Int Health"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/erm.12.72","volume":"12","author":"Deborggraeve S.","year":"2012","unstructured":"Deborggraeve S.; B\u00fcscher P.; Recent progress in molecular diagnosis of sleeping sickness. Expert Rev Mol Diagn 2012,12(7),719-730","journal-title":"Expert Rev Mol Diagn"},{"key":"ref=21","unstructured":"WHO includes combination of\neflornithine and nifurtimox in its Essential List of Medicines\nfor the treatment of human African trypanosomiasis, 2009\nAvailable at: World Health Organization(Accessed: 17 February, 2018).","journal-title":"WHO includes combination of\neflornithine and nifurtimox in its Essential List of Medicines\nfor the treatment of human African trypanosomiasis, 2009\nAvailable at:"},{"key":"ref=22","author":"Ranjbarian F.","year":"2017","unstructured":"Ranjbarian F.;  Targets and strategies for drug development against human African sleeping sickness Available at:(Accessed: March, 2018).2017","journal-title":"Targets and strategies for drug development against human African sleeping sickness"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000720","volume":"4","author":"Yun O.","year":"2010","unstructured":"Yun O.; Priotto G.; Tong J.; Flevaud L.; Chappuis F.; NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness. PLoS Negl Trop Dis 2010,4(5)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=24","year":"2009","unstructured":"Drugs for Neglected Diseases initiative. Human African\ntrypanosomiasis: Target Product Profile (TPP) Available at:(Accessed: 17 February, 2018).2009","journal-title":"Human African\ntrypanosomiasis: Target Product Profile (TPP)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-94-007-7305-9_2","volume":"74","author":"Smirlis D.","year":"2014","unstructured":"Smirlis D.; Soares M.B.; Selection of molecular targets for drug development against Trypanosomatids. Pro Proteo Leish Tryp 2014,74,43-76","journal-title":"Pro Proteo Leish Tryp"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.3390\/molecules19055550","volume":"19","author":"Bernal F.A.","year":"2014","unstructured":"Bernal F.A.; Coy-Barrera E.; \n                        In-silico analyses of sesquiterpene-related compounds on selected Leishmania enzyme-based targets. Molecules 2014,19(5),5550-5569","journal-title":"Molecules"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1590\/S0100-40422000000200007","volume":"23","author":"Leitao A.","year":"2000","unstructured":"Leitao A.; Montanari C.A.; Donnici C.L.; The use of chemometric methods on combinatorial chemistry. Quim Nova 2000,23(2),178-184","journal-title":"Quim Nova"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/0929867003375317","volume":"7","author":"Ooms F.","year":"2000","unstructured":"Ooms F.; Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry. Curr Med Chem 2000,7(2),141-158","journal-title":"Curr Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1016\/j.bmc.2012.04.062","volume":"20","author":"Duffy B.C.","year":"2012","unstructured":"Duffy B.C.; Zhu L.; Decornez H.; Kitchen D.B.; Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. Bioorg Med Chem 2012,20(18),5324-5342","journal-title":"Bioorg Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejmech.2017.10.005","volume":"141","author":"Uliassi E.","year":"2017","unstructured":"Uliassi E.; Fiorani G.; Krauth-Siegel R.L.; Bergamini C.; Fato R.; Bianchini G.; Carlos Men\u00e9ndez J.; Molina M.T.; L\u00f3pez-Montero E.; Falchi F.; Cavalli A.; Gul S.; Kuzikov M.; Ellinger B.; Witt G.; Moraes C.B.; Freitas-Junior L.H.; Borsari C.; Costi M.P.; Bolognesi M.L.; Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity. Eur J Med Chem 2017,141,138-148","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001727","volume":"6","author":"Setzer W.N.","year":"2012","unstructured":"Setzer W.N.; Ogungbe I.V.; \n                        In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants. PLoS Negl Trop Dis 2012,6(7)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbagen.2015.10.015","volume":"1860","author":"Xiaofeng Y.U.","year":"2016","unstructured":"Xiaofeng Y.U.; Prajwal N.; Ghulam M.; Vlad C.; Galina I.L.; Rebecca C.W.; Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design. Biochim Biophys Acta 2016,1860(100),67-78","journal-title":"Biochim Biophys Acta"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/ci060046x","volume":"47","author":"Hristozov D.","year":"2007","unstructured":"Hristozov D.; Da Costa F.B.; Gasteiger J.; Sesquiterpene lactones-based classification of the family asteraceae using neural networks and k-nearest neighbors. J Chem Inf Model 2007,47(1),9-19","journal-title":"J Chem Inf Model"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.phytochem.2004.12.006","volume":"66","author":"Da Costa F.B.","year":"2005","unstructured":"Da Costa F.B.; Terfloth L.; Gasteiger J.; Sesquiterpene lactone-based classification of three Asteraceae tribes: a study based on self-organizing neural networks applied to chemosystematics. Phytochemistry 2005,66(3),345-353","journal-title":"Phytochemistry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1016\/j.bmc.2007.02.005","volume":"15","author":"Scotti M.T.","year":"2007","unstructured":"Scotti M.T.; Fernandes M.B.; Ferreira M.J.; Emerenciano V.P.; Quantitative structure-activity relationship of sesquiterpene lactones with cytotoxic activity. Bioorg Med Chem 2007,15(8),2927-2934","journal-title":"Bioorg Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/S0968-0896(01)00131-6","volume":"9","author":"Heilmann J.","year":"2001","unstructured":"Heilmann J.; Wasescha M.R.; Schmidt T.J.; The influence of glutathione and cysteine levels on the cytotoxicity of helenanolide type sesquiterpene lactones against KB cells. Bioorg Med Chem 2001,9(8),2189-2194","journal-title":"Bioorg Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1055\/s-2006-959526","volume":"60","author":"Woerdenbag H.J.","year":"1994","unstructured":"Woerdenbag H.J.; Merfort I.; Passreiter C.M.; Schmidt T.J.; Willuhn G.; van Uden W.; Pras N.; Kampinga H.H.; Konings A.W.; Cytotoxicity of flavonoids and sesquiterpene lactones from Arnica species against the GLC4 and the COLO 320 cell lines. Planta Med 1994,60(5),434-437","journal-title":"Planta Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.3390\/molecules17044684","volume":"17","author":"Scotti M.T.","year":"2012","unstructured":"Scotti M.T.; Emerenciano V.; Ferreira M.J.; Scotti L.; Stefani R.; da Silva M.S.; Mendon\u00e7a Junior, F.J.; Self-organizing maps of molecular descriptors for sesquiterpene lactones and their application to the chemotaxonomy of the Asteraceae family. Molecules 2012,17(4),4684-4702","journal-title":"Molecules"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000648","volume":"6","author":"Durrant J.D.","year":"2010","unstructured":"Durrant J.D.; Amaro R.E.; Xie L.; Urbaniak M.D.; Ferguson M.A.J.; Haapalainen A.; Chen Z.; Di Guilmi A.M.; Wunder F.; Bourne P.E.; McCammon J.A.; A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology. PLOS Comput Biol 2010,6(1)","journal-title":"PLOS Comput Biol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/1062936X.2017.1292407","volume":"28","author":"Masand V.H.","year":"2017","unstructured":"Masand V.H.; El-Sayed N.N.E.; Mahajan D.T.; Rastija V.; QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitors. SAR QSAR Environ Res 2017,28(2),165-177","journal-title":"SAR QSAR Environ Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"16154","DOI":"10.3390\/molecules200916154","volume":"20","author":"Fabian C.","year":"2015","unstructured":"Fabian C.; Herrmann, Mairin Lenz, Joachim Jose, Marcel Kaiser, Reto Brun and Thomas J. Schmidt. In silico identification and in vitro activity of novel natural inhibitors of Trypanosoma brucei glyceraldehyde-3-phosphatede-hydrogenase. Molecules 2015,20(9),16154-16169","journal-title":"Molecules"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/nar\/gkx1198","volume":"46","author":"Srivastava A.","year":"2018","unstructured":"Srivastava A.; Badjatia N.; Lee J.H.; Hao B.; G\u00fcnzl A.; An RNA polymerase II-associated TFIIF-like complex is indispensable for SL RNA gene transcription in Trypanosoma brucei. Nucleic Acids Res 2018,46(4),1695-1709","journal-title":"Nucleic Acids Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/AAC.01263-13","volume":"58","author":"Schmidt T.J.","year":"2014","unstructured":"Schmidt T.J.; Da Costa F.B.; Lopes N.P.; Kaiser M.; Brun R.; \n                        In silico prediction and experimental evaluation of furanoheliangolide sesquiterpene lactones as potent agents against Trypanosoma brucei rhodesiense. Antimicrob Agents Chemother 2014,58(1),325-332","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1126\/science.aal1807","volume":"355","author":"Dawidowski M.","year":"2017","unstructured":"Dawidowski M.; Emmanouilidis L.; Kalel V.C.; Tripsianes K.; Schorpp K.; Hadian K.; Kaiser M.; M\u00e4ser P.; Kolonko M.; Tanghe S.; Rodriguez A.; Schliebs W.; Erdmann R.; Sattler M.; Popowicz G.M.; Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites. Science 2017,355(6332),1416-1420","journal-title":"Science"},{"key":"ref=45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000803","volume":"4","author":"Durrant J.D.","year":"2010","unstructured":"Durrant J.D.; Hall L.; Swift R.V.; Landon M.; Schnaufer A.; Amaro R.E.; Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1. PLoS Negl Trop Dis 2010,4(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"16154","DOI":"10.3390\/molecules200916154","volume":"20","author":"Herrmann F.C.","year":"2015","unstructured":"Herrmann F.C.; Lenz M.; Jose J.; Kaiser M.; Brun R.; Schmidt T.J.; \n                        In silico identification and in vitro activity of novel natural inhibitors of Trypanosoma brucei glyceraldehyde-3-phosphate-dehydrogenase. Molecules 2015,20(9),16154-16169","journal-title":"Molecules"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens6030032","volume":"6","author":"Rodrigo J.","year":"2017","unstructured":"Rodrigo J.; Diogo T.; Alberto A.M.R.; D\u00e1 vila. ProtozoaDB 2.0: A Trypanosoma brucei case study. Pathogens 2017,6(32),1-13","journal-title":"Pathogens"},{"key":"ref=48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003253","volume":"8","author":"Diaz R.","year":"2014","unstructured":"Diaz R.; Luengo-Arratta S.A.; Seixas J.D.; Amata E.; Devine W.; Cordon-Obras C.; Rojas-Barros D.I.; Jimenez E.; Ortega F.; Crouch S.; Colmenarejo G.; Fiandor J.M.; Martin J.J.; Berlanga M.; Gonzalez S.; Manzano P.; Navarro M.; Pollastri M.P.; Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign. PLoS Negl Trop Dis 2014,8(10)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188219","volume":"12","author":"Steinmann M.E.","year":"2017","unstructured":"Steinmann M.E.; Schmidt R.S.; Mac\u00eado J.P.; Kunz Renggli C.; B\u00fctikofer P.; Rentsch D.; M\u00e4ser P.; Sigel E.; Identification and characterization of the three members of the CLC family of anion transport proteins in Trypanosoma brucei. PLoS One 2017,12(12)","journal-title":"PLoS One"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005886","volume":"11","author":"Tulloch L.B.","year":"2017","unstructured":"Tulloch L.B.; Menzies S.K.; Fraser A.L.; Gould E.R.; King E.F.; Zacharova M.K.; Florence G.J.; Smith T.K.; Photo-affinity labelling and biochemical analyses identify the target of trypanocidal simplified natural product analogues. PLoS Negl Trop Dis 2017,11(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejmech.2011.12.028","volume":"48","author":"D\u00fcr\u00fcst Y.","year":"2012","unstructured":"D\u00fcr\u00fcst Y.; Karaku\u015f H.; Kaiser M.; Tasdemir D.; Synthesis and anti-protozoal activity of novel dihydropyrrolo[3,4-d][1,2,3]triazoles. Eur J Med Chem 2012,48,296-304","journal-title":"Eur J Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0306-3623(97)00268-1","volume":"30","author":"Bala\u00f1a-Fouce R.","year":"1998","unstructured":"Bala\u00f1a-Fouce R.; Reguera R.M.; Cubr\u00eda J.C.; Ord\u00f3\u00f1ez D.; The pharmacology of leishmaniasis. Gen Pharmacol 1998,30(4),435-443","journal-title":"Gen Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jep.2008.08.007","volume":"120","author":"Santos A.O.","year":"2008","unstructured":"Santos A.O.; Ueda-Nakamura T.; Dias Filho B.P.; Veiga Junior, V.F.; Pinto A.C.; Nakamura C.V.; Effect of Brazilian copaiba oils on Leishmania amazonensis. J Ethnopharmacol 2008,120(2),204-208","journal-title":"J Ethnopharmacol"},{"key":"ref=54","year":"2013","unstructured":"Leishmaniasis WHO - World Health Organization.2013","journal-title":"Leishmaniasis"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bmc.2013.11.048","volume":"22","author":"Singh N.","year":"2014","unstructured":"Singh N.; Mishra B.B.; Bajpai S.; Singh R.K.; Tiwari V.K.; Natural product based leads to fight against leishmaniasis. Bioorg Med Chem 2014,22(1),18-45","journal-title":"Bioorg Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/626838","volume":"2012626838","author":"Bhargava P.","year":"2012","unstructured":"Bhargava P.; Singh R.; Developments in diagnosis and antileishmanial drugs. Interdiscip Perspect Infect Dis 2012,2012626838","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref=57","year":"2015","unstructured":"WHO - World Health Organization. Leishmaniasis Available at:2015","journal-title":"Leishmaniasis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"Croft S.L.","year":"2006","unstructured":"Croft S.L.; Sundar S.; Fairlamb A.H.; Drug resistance in leishmaniasis. Clin Microbiol Rev 2006,19(1),111-126","journal-title":"Clin Microbiol Rev"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"Alvar J.","year":"2012","unstructured":"Alvar J.; V\u00e9lez I.D.; Bern C.; Herrero M.; Desjeux P.; Cano J.; Jannin J.; den Boer M.; WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012,7(5)","journal-title":"PLoS One"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002213","volume":"7","author":"Karagiannis-Voules D-A.","year":"2013","unstructured":"Karagiannis-Voules D-A.; Scholte R.G.C.; Guimar\u00e3es L.H.; Utzinger J.; Vounatsou P.; Bayesian geostatistical modeling of leishmaniasis incidence in Brazil. PLoS Negl Trop Dis 2013,7(5)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=61","first-page":"268","volume":"4","author":"Micheletti A.C.","year":"2012","unstructured":"Micheletti A.C.; Beatriz A.; Progressos recentes na pesquisa de compostos org\u00e2nicos com potencial atividade leishmanicida. Rev. Virtual Qu\u00edm 2012,4,268-286","journal-title":"Virtual Qu\u00edm"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","volume":"17","author":"Croft S.L.","year":"2011","unstructured":"Croft S.L.; Olliaro P.; Leishmaniasis chemotherapy--challenges and opportunities. Clin Microbiol Infect 2011,17(10),1478-1483","journal-title":"Clin Microbiol Infect"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1016\/j.vaccine.2012.03.068","volume":"30","author":"Singh B.","year":"2012","unstructured":"Singh B.; Sundar S.; Leishmaniasis: vaccine candidates and perspectives. Vaccine 2012,30(26),3834-3842","journal-title":"Vaccine"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2011.01.044","volume":"408","author":"Iman M.","year":"2011","unstructured":"Iman M.; Huang Z.; Szoka F.C.; Jaafari M.R.; Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a distigmasterylhemisuccinoyl-glycero-phosphocholine. Int J Pharm 2011,408(1-2),163-172","journal-title":"Int J Pharm"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","volume":"63","author":"Mitropoulos P.","year":"2010","unstructured":"Mitropoulos P.; Konidas P.; Durkin-Konidas M.; New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol 2010,63(2),309-322","journal-title":"J Am Acad Dermatol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","volume":"95","author":"Desjeux P.","year":"2001","unstructured":"Desjeux P.; The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001,95(3),239-243","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.eimc.2009.06.010","volume":"27","author":"Coll P.","year":"2009","unstructured":"Coll P.; [Active drugs against Mycobacterium tuberculosis.]. Enferm Infecc Microbiol Clin 2009,27(8),474-480","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref=68","first-page":"733","volume":"3","author":"Sundar S.","year":"2007","unstructured":"Sundar S.; Olliaro P.L.; Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management. Ther Clin Risk Manag 2007,3(5),733-740","journal-title":"Ther Clin Risk Manag"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1472-6882-13-48","volume":"13","author":"Malebo H.M.","year":"2013","unstructured":"Malebo H.M.; Wenzler T.; Cal M.; Swaleh S.M.; Omolo M.O.; Hassanali A.; S\u00e9quin U.; H\u00e4ussinger D.; Dalsgaard P.; Hamburger M.; Brun R.; Ndiege I.O.; Anti-protozoal activity of aporphine and protoberberine alkaloids from Annickia kummeriae (Engl.","journal-title":"BMC Complement Altern Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.abb.2015.05.011","volume":"582","author":"Cerqueira N.M.","year":"2015","unstructured":"Cerqueira N.M.; Gesto D.; Oliveira E.F.; Santos-Martins D.; Br\u00e1s N.F.; Sousa S.F.; Fernandes P.A.; Ramos M.J.; Receptor-based virtual screening protocol for drug discovery. Arch Biochem Biophys 2015,582,56-67","journal-title":"Arch Biochem Biophys"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejmech.2016.03.022","volume":"115","author":"Rashid U.","year":"2016","unstructured":"Rashid U.; Sultana R.; Shaheen N.; Hassan S.F.; Yaqoob F.; Ahmad M.J.; Iftikhar F.; Sultana N.; Asghar S.; Yasinzai M.; Ansari F.L.; Qureshi N.A.; Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents. Eur J Med Chem 2016,115,230-244","journal-title":"Eur J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1021\/acs.jcim.6b00642","volume":"57","author":"Agnihotri P.","year":"2017","unstructured":"Agnihotri P.; Mishra A.K.; Mishra S.; Sirohi V.K.; Sahasrabuddhe A.A.; Pratap J.V.; Identification of novel inhibitors of Leishmania donovani \u03b3-Glutamylcysteine synthetase using structure-based virtual screening, docking, molecular dynamics simulation, and in vitro studies. J Chem Inf Model 2017,57(4),815-825","journal-title":"J Chem Inf Model"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002499","volume":"8","author":"Jacob R.B.","year":"2012","unstructured":"Jacob R.B.; Andersen T.; McDougal O.M.; Accessible high-throughput virtual screening molecular docking software for students and educators. PLOS Comput Biol 2012,8(5)","journal-title":"PLOS Comput Biol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"Meng X.Y.","year":"2011","unstructured":"Meng X.Y.; Zhang H.X.; Mezei M.; Cui M.; Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 2011,7(2),146-157","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2174\/1386207319666160907100134","volume":"19","author":"Pandey R.K.","year":"2016","unstructured":"Pandey R.K.; Prajapati P.; Goyal S.; Grover A.; Prajapati V.K.; Molecular modeling and virtual screening approach to discover potential antileishmanial inhibitors against ornithine decarboxylase. Comb Chem High Throughput Screen 2016,19(10),813-823","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.bjp.0707305","volume":"152","author":"Ekins S.","year":"2007","unstructured":"Ekins S.; Mestres J.; Testa B.; \n                        In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol 2007,152(1),9-20","journal-title":"Br J Pharmacol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2174\/1568026023392841","volume":"2","author":"Darvas F.","year":"2002","unstructured":"Darvas F.; Keseru G.; Papp A.; Dorm\u00e1n G.; Urge L.; Krajcsi P.; \n                        In silico and ex silico ADME approaches for drug discovery. Curr Top Med Chem 2002,2(12),1287-1304","journal-title":"Curr Top Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","volume":"22","author":"DiMasi J.A.","year":"2003","unstructured":"DiMasi J.A.; Hansen R.W.; Grabowski H.G.; The price of innovation: new estimates of drug development costs. J Health Econ 2003,22(2),151-185","journal-title":"J Health Econ"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/amiajnl-2013-001700","volume":"21","author":"Sateriale A.","year":"2014","unstructured":"Sateriale A.; Bessoff K.; Sarkar I.N.; Huston C.D.; Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds. J Am Med Inform Assoc 2014,21(2),238-244","journal-title":"J Am Med Inform Assoc"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1021\/ci500585w","volume":"55","author":"Fraczkiewicz R.","year":"2015","unstructured":"Fraczkiewicz R.; Lobell M.; G\u00f6ller A.H.; Krenz U.; Schoenneis R.; Clark R.D.; Hillisch A.; Best of both worlds: combining pharma data and state of the art modeling technology to improve in Silico pKa prediction. J Chem Inf Model 2015,55(2),389-397","journal-title":"J Chem Inf Model"},{"key":"ref=81","doi-asserted-by":"publisher","DOI":"10.5936\/csbj.201302011","volume":"5","author":"Lounnas V.","year":"2013","unstructured":"Lounnas V.; Ritschel T.; Kelder J.; McGuire R.; Bywater R.P.; Foloppe N.; Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery. Comput Struct Biotechnol J 2013,5","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=82","first-page":"111","volume":"118","author":"Marr J.J.","year":"1991","unstructured":"Marr J.J.; Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J Lab Clin Med 1991,118(2),111-119","journal-title":"J Lab Clin Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1016\/j.bmc.2012.06.051","volume":"20","author":"Eri\u0107 S.","year":"2012","unstructured":"Eri\u0107 S.; Ke S.; Barata T.; Solmajer T.; Anti\u0107 Stankovi\u0107 J.; Jurani\u0107 Z.; Savi\u0107 V.; Zloh M.; Target fishing and docking studies of the novel derivatives of aryl-aminopyridines with potential anticancer activity. Bioorg Med Chem 2012,20(17),5220-5228","journal-title":"Bioorg Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1021\/jm0493717","volume":"47","author":"Desai P.V.","year":"2004","unstructured":"Desai P.V.; Patny A.; Sabnis Y.; Tekwani B.; Gut J.; Rosenthal P.; Srivastava A.; Avery M.; Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. J Med Chem 2004,47(26),6609-6615","journal-title":"J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"917","DOI":"10.5897\/AJMR-11-738","volume":"6","author":"Adibpour N.","year":"2012","unstructured":"Adibpour N.; Rahim F.; Rezaeei S.; Khalaj A.; Ebrahimi A.; \n                        In silico designing selective inhibitor of drugs, medicinal plants compounds and experimental ligands for pteridine reductase targeting visceral leishmaniasis. Afr J Microbiol Res 2012,6(5),917-926","journal-title":"Afr J Microbiol Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1747-0285.2011.01262.x","volume":"79","author":"Gangwar S.","year":"2012","unstructured":"Gangwar S.; Baig M.S.; Shah P.; Biswas S.; Batra S.; Siddiqi M.I.; Goyal N.; Identification of novel inhibitors of dipeptidylcarboxypeptidase of Leishmania donovani via ligand-based virtual screening and biological evaluation. Chem Biol Drug Des 2012,79(2),149-156","journal-title":"Chem Biol Drug Des"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cbi.2016.12.004","volume":"263","author":"Figueroa-Villar J.D.","year":"2017","unstructured":"Figueroa-Villar J.D.; Sales E.M.; The importance of nucleoside hydrolase enzyme (NH) in studies to treatment of Leishmania: A review. Chem Biol Interact 2017,263,18-27","journal-title":"Chem Biol Interact"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0166-6851(01)00213-4","volume":"113","author":"Cunningham M.L.","year":"2001","unstructured":"Cunningham M.L.; Beverley S.M.; Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy. Mol Biochem Parasitol 2001,113(2),199-213","journal-title":"Mol Biochem Parasitol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"11442","DOI":"10.1073\/pnas.91.24.11442","volume":"91","author":"Bello A.R.","year":"1994","unstructured":"Bello A.R.; Nare B.; Freedman D.; Hardy L.; Beverley S.M.; PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major. Proc Natl Acad Sci USA 1994,91(24),11442-11446","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jmgm.2017.07.013","volume":"76","author":"Romero A.H.","year":"2017","unstructured":"Romero A.H.; L\u00f3pez S.E.; \n                        In silico molecular docking studies of new potential 4-phthalazinyl-hydrazones on selected Trypanosoma cruzi and Leishmania enzyme targets. J Mol Graph Model 2017,76,313-329","journal-title":"J Mol Graph Model"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.1112181","volume":"309","author":"El-Sayed N.M.","year":"2005","unstructured":"El-Sayed N.M.; Myler P.J.; Blandin G.; Berriman M.; Crabtree J.; Aggarwal G.; Caler E.; Renauld H.; Worthey E.A.; Hertz-Fowler C.; Ghedin E.; Peacock C.; Bartholomeu D.C.; Haas B.J.; Tran A.N.; Wortman J.R.; Alsmark U.C.; Angiuoli S.; Anupama A.; Badger J.; Bringaud F.; Cadag E.; Carlton J.M.; Cerqueira G.C.; Creasy T.; Delcher A.L.; Djikeng A.; Embley T.M.; Hauser C.; Ivens A.C.; Kummerfeld S.K.; Pereira-Leal J.B.; Nilsson D.; Peterson J.; Salzberg S.L.; Shallom J.; Silva J.C.; Sundaram J.; Westenberger S.; White O.; Melville S.E.; Donelson J.E.; Andersson B.; Stuart K.D.; Hall N.; Comparative genomics of trypanosomatid parasitic protozoa. Science 2005,309(5733),404-409","journal-title":"Science"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056788","volume":"8","author":"Koch O.","year":"2013","unstructured":"Koch O.; Cappel D.; Nocker M.; J\u00e4ger T.; Floh\u00e9 L.; Sotriffer C.A.; Selzer P.M.; Molecular dynamics reveal binding mode of glutathionylspermidine by trypanothione synthetase. PLoS One 2013,8(2)","journal-title":"PLoS One"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0166-6851(91)90126-Q","volume":"49","author":"Beck J.T.","year":"1991","unstructured":"Beck J.T.; Ullman B.; Biopterin conversion to reduced folates by Leishmania donovani promastigotes. Mol Biochem Parasitol 1991,49(1),21-28","journal-title":"Mol Biochem Parasitol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/AAC.40.4.947","volume":"40","author":"Callahan H.L.","year":"1996","unstructured":"Callahan H.L.; Kelley C.; Pereira T.; Grogl M.; Microtubule inhibitors: structure-activity analyses suggest rational models to identify potentially active compounds. Antimicrob Agents Chemother 1996,40(4),947-952","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0166-6851(98)00146-7","volume":"98","author":"Werbovetz K.A.","year":"1999","unstructured":"Werbovetz K.A.; Brendle J.J.; Sackett D.L.; Purification, characterization, and drug susceptibility of tubulin from Leishmania. Mol Biochem Parasitol 1999,98(1),53-65","journal-title":"Mol Biochem Parasitol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/14756360310001624966","volume":"19","author":"Castro-Pinto D.B.","year":"2004","unstructured":"Castro-Pinto D.B.; Echevarria A.; Genestra M.S.; Cysne-Finkelstein L.; Leon L.L.; Trypanothione reductase activity is prominent in metacyclic promastigotes and axenic amastigotes of Leishmania amazonesis. Evaluation of its potential as a therapeutic target. J Enzyme Inhib Med Chem 2004,19(1),57-63","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1128\/AAC.40.3.706","volume":"40","author":"Slunt K.M.","year":"1996","unstructured":"Slunt K.M.; Grace J.M.; Macdonald T.L.; Pearson R.D.; Effect of mitonafide analogs on topoisomerase II of Leishmania chagasi. Antimicrob Agents Chemother 1996,40(3),706-709","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/978-1-4419-8414-2_6","volume":"712","author":"Caffrey C.R.","year":"2011","unstructured":"Caffrey C.R.; Lima A.P.; Steverding D.; Cysteine peptidases of kinetoplastid parasites. Adv Exp Med Biol 2011,712,84-99","journal-title":"Adv Exp Med Biol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/cmdc.201000420","volume":"6","author":"Eberle C.","year":"2011","unstructured":"Eberle C.; Lauber B.S.; Fankhauser D.; Kaiser M.; Brun R.; Krauth-Siegel R.L.; Diederich F.; Improved inhibitors of trypanothione reductase by combination of motifs: synthesis, inhibitory potency, binding mode, and antiprotozoal activities. ChemMedChem 2011,6(2),292-301","journal-title":"ChemMedChem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/1471-2164-12-614","volume":"12","author":"Palmeri A.","year":"2011","unstructured":"Palmeri A.; Gherardini P.F.; Tsigankov P.; Ausiello G.; Sp\u00e4th G.F.; Zilberstein D.; Helmer-Citterich M.; PhosTryp: a phosphorylation site predictor specific for parasitic protozoa of the family trypanosomatidae. BMC Genomics 2011,12,614","journal-title":"BMC Genomics"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/molecules21050589","volume":"21","author":"Glisic S.","year":"2016","unstructured":"Glisic S.; Sencanski M.; Perovic V.; Stevanovic S.; Garc\u00eda-Sosa A.T.; Arginase flavonoid anti-Leishmanial in silico inhibitors flagged against anti-targets. Molecules 2016,21(5),589","journal-title":"Molecules"},{"key":"ref=102","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902017000116067","volume":"53","author":"Lavorato S.N.","year":"2017","unstructured":"Lavorato S.N.; Duarte M.C.; Andrade P.H.R.D.; Coelho E.A.F.; Alves R.J.; Synthesis, antileishmanial activity and QSAR studies of 2-chloro-N-arylacetamides. Braz J Pharm Sci 2017,53(1)","journal-title":"Braz J Pharm Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/cem.2789","volume":"30","author":"Tahghighi A.","year":"2016","unstructured":"Tahghighi A.; Hamzeh\u2010Mivehroud M.; Asadpour Zeynali K.; Foroumadi A.; Dastmalchi S.; QSAR and docking studies on the (5\u2010nitroheteroaryl\u20101, 3, 4\u2010thiadiazole\u20102\u2010yl) piperazinyl analogs with antileishmanial activity. J Chemometr 2016,30(5),284-293","journal-title":"J Chemometr"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-4020-6051-9_11","volume":"44","author":"Krauth-Siegel L.R.","year":"2007","unstructured":"Krauth-Siegel L.R.; Comini M.A.; Schlecker T.; The trypanothione system. Subcell Biochem 2007,44,231-251","journal-title":"Subcell Biochem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molbiopara.2015.11.003","volume":"206","author":"Leroux A.E.","year":"2016","unstructured":"Leroux A.E.; Krauth-Siegel R.L.; Thiol redox biology of trypanosomatids and potential targets for chemotherapy. Mol Biochem Parasitol 2016,206(1-2),67-74","journal-title":"Mol Biochem Parasitol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.4155\/fmc.13.146","volume":"5","author":"Colotti G.","year":"2013","unstructured":"Colotti G.; Baiocco P.; Fiorillo A.; Boffi A.; Poser E.; Chiaro F.D.; Ilari A.; Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs. Future Med Chem 2013,5(15),1861-1875","journal-title":"Future Med Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0022-2836(92)90701-K","volume":"227","author":"Hunter W.N.","year":"1992","unstructured":"Hunter W.N.; Bailey S.; Habash J.; Harrop S.J.; Helliwell J.R.; Aboagye-Kwarteng T.; Smith K.; Fairlamb A.H.; Active site of trypanothione reductase. A target for rational drug design. J Mol Biol 1992,227(1),322-333","journal-title":"J Mol Biol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/j.bmcl.2017.03.049","volume":"27","author":"Masood M.M.","year":"2017","unstructured":"Masood M.M.; Hasan P.; Tabrez S.; Ahmad M.B.; Yadava U.; Daniliuc C.G.; Sonawane Y.A.; Azam A.; Rub A.; Abid M.; Anti-leishmanial and cytotoxic activities of amino acid-triazole hybrids: Synthesis, biological evaluation, molecular docking and in silico physico-chemical properties. Bioorg Med Chem Lett 2017,27(9),1886-1891","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bcp.2016.12.012","volume":"129","author":"Ramu D.","year":"2017","unstructured":"Ramu D.; Garg S.; Ayana R.; Keerthana A.K.; Sharma V.; Saini C.P.; Sen S.; Pati S.; Singh S.; Novel \u03b2-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity. Biochem Pharmacol 2017,129,26-42","journal-title":"Biochem Pharmacol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2015.10.011","volume":"106","author":"Rodrigues K.A.F.","year":"2015","unstructured":"Rodrigues K.A.F.; Dias C.N.S.; N\u00e9ris P.L.N.; Rocha, Jda.C.; Scotti, M.T.; Scotti, L.; Mascarenhas, S.R.; Veras, R.C.; de Medeiros, I.A.; Keesen, Tde.S.; de Oliveira, T.B.; de Lima, Mdo.C.; Balliano, T.L.; de Aquino, T.M.; de Moura, R.O.; Mendon\u00e7a Junior, F.J.; de Oliveira, M.R. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro. Eur J Med Chem 2015,106,1-14","journal-title":"Eur J Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/1934578X1501000630","volume":"10","author":"Ribeiro F.F.","year":"2015","unstructured":"Ribeiro F.F.; Junior F.J.B.M.; da Silva M.S.; Scotti M.T.; Scotti L.; Computational and investigative study of flavonoids active against Trypanosoma cruzi and Leishmania spp. Nat Prod Commun 2015,10(6),917-920","journal-title":"Nat Prod Commun"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biopha.2016.06.010","volume":"83","author":"Pandey R.K.","year":"2016","unstructured":"Pandey R.K.; Verma P.; Sharma D.; Bhatt T.K.; Sundar S.; Prajapati V.K.; High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania. Biomed Pharmacother 2016,83,141-152","journal-title":"Biomed Pharmacother"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jmgm.2013.12.010","volume":"48","author":"Ogungbe I.V.","year":"2014","unstructured":"Ogungbe I.V.; Erwin W.R.; Setzer W.N.; Antileishmanial phytochemical phenolics: molecular docking to potential protein targets. J Mol Graph Model 2014,48,105-117","journal-title":"J Mol Graph Model"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00436-014-3850-8","volume":"113","author":"Villalobos-Rocha J.C.","year":"2014","unstructured":"Villalobos-Rocha J.C.; S\u00e1nchez-Torres L.; Nogueda-Torres B.; Segura-Cabrera A.; Garc\u00eda-P\u00e9rez C.A.; Bocanegra-Garc\u00eda V.; Palos I.; Monge A.; Rivera G.; Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives. Parasitol Res 2014,113(6),2027-2035","journal-title":"Parasitol Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"353","DOI":"10.6026\/97320630010353","volume":"10","author":"Gundampati R.K.","year":"2014","unstructured":"Gundampati R.K.; Sahu S.; Shukla A.; Pandey R.K.; Patel M.; Banik R.M.; Jagannadham M.V.; Tryparedoxin peroxidase of Leishmania braziliensis: homology modeling and inhibitory effects of flavonoids for anti-leishmanial activity. Bioinformation 2014,10(6),353-357","journal-title":"Bioinformation"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1021\/acs.joc.6b00113","volume":"81","author":"Dar A.A.","year":"2016","unstructured":"Dar A.A.; Shadab M.; Khan S.; Ali N.; Khan A.T.; One-Pot synthesis and evaluation of antileishmanial activities of functionalized S-Alkyl\/Aryl benzothiazole-2-carbothioate scaffold. J Org Chem 2016,81(8),3149-3160","journal-title":"J Org Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.4155\/fmc-2018-0512","volume":"11","author":"das Neves G.M.","year":"2019","unstructured":"das Neves G.M.; Kagami L.P.; Gon\u00e7alves I.L.; Eifler-Lima, . V.L.; Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery. Future Med Chem 2019,11(16),2107-2130","journal-title":"Future Med Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1080\/07391102.2015.1085904","volume":"33","author":"Pandey R.K.","year":"2015","unstructured":"Pandey R.K.; Sharma D.; Bhatt T.K.; Sundar S.; Prajapati V.K.; Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach. J Biomol Struct Dyn 2015,33(12),2541-2553","journal-title":"J Biomol Struct Dyn"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/07391102.2015.1135298","volume":"35","author":"Pandey R.K.","year":"2017","unstructured":"Pandey R.K.; Kumbhar B.V.; Srivastava S.; Malik R.; Sundar S.; Kunwar A.; Prajapati V.K.; Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation. J Biomol Struct Dyn 2017,35(1),141-158","journal-title":"J Biomol Struct Dyn"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/10799893.2016.1171344","volume":"37","author":"Pandey R.K.","year":"2017","unstructured":"Pandey R.K.; Kumbhar B.V.; Sundar S.; Kunwar A.; Prajapati V.K.; Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase. J Recept Signal Transduct Res 2017,37(1),60-70","journal-title":"J Recept Signal Transduct Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ardp.201500312","volume":"349","author":"Rauf M.K.","year":"2016","unstructured":"Rauf M.K.; Shaheen U.; Asghar F.; Badshah A.; Nadhman A.; Azam S.; Ali M.I.; Shahnaz G.; Yasinzai M.; Antileishmanial, DNA interaction, and docking studies of some ferrocene-based heteroleptic pentavalent antimonials. Arch Pharm (Weinheim) 2016,349(1),50-62","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2174\/1386207319666160907102235","volume":"19","author":"Iman M.","year":"2016","unstructured":"Iman M.; Kaboutaraki H.B.; Jafari R.; Hosseini S.A.; Moghimi A.; Khamesipour A.; Harchegani A.B.; Davood A.; Molecular dynamics simulation and docking studies of selenocyanate derivatives as anti-leishmanial agents. Comb Chem High Throughput Screen 2016,19(10),847-854","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00018-017-2653-3","volume":"75","author":"Vishwakarma P.","year":"2018","unstructured":"Vishwakarma P.; Parmar N.; Chandrakar P.; Sharma T.; Kathuria M.; Agnihotri P.K.; Siddiqi M.I.; Mitra K.; Kar S.; Ammonium trichloro [1,2-ethanediolato-O,O\u2032]-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K\/Akt pathway. Cell Mol Life Sci 2018,75(3),563-588","journal-title":"Cell Mol Life Sci"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.bmcl.2015.12.085","volume":"26","author":"Sangshetti J.N.","year":"2016","unstructured":"Sangshetti J.N.; Kalam Khan F.A.; Kulkarni A.A.; Patil R.H.; Pachpinde A.M.; Lohar K.S.; Shinde D.B.; Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction. Bioorg Med Chem Lett 2016,26(3),829-835","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/ijms17071141","volume":"17","author":"Gao J.","year":"2016","unstructured":"Gao J.; Liang L.; Zhu Y.; Qiu S.; Wang T.; Zhang L.; Ligand and structure-based approaches for the identification of peptide deformylase inhibitors as antibacterial drugs. Int J Mol Sci 2016,17(7),1141-1150","journal-title":"Int J Mol Sci"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bioorg.2017.02.005","volume":"71","author":"Taha M.","year":"2017","unstructured":"Taha M.; Ismail N.H.; Ali M.; Rashid U.; Imran S.; Uddin N.; Khan K.M.; Molecular hybridization conceded exceptionally potent quinolinyl-oxadiazole hybrids through phenyl linked thiosemicarbazide antileishmanial scaffolds: In silico validation and SAR studies. Bioorg Chem 2017,71,192-200","journal-title":"Bioorg Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"10429","DOI":"10.1074\/jbc.M110.209593","volume":"286","author":"Ong H.B.","year":"2011","unstructured":"Ong H.B.; Sienkiewicz N.; Wyllie S.; Fairlamb A.H.; Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major. J Biol Chem 2011,286(12),10429-10438","journal-title":"J Biol Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1365-2958.2010.07236.x","volume":"77","author":"Sienkiewicz N.","year":"2010","unstructured":"Sienkiewicz N.; Ong H.B.; Fairlamb A.H.; \n                        Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice. Mol Microbiol 2010,77(3),658-671","journal-title":"Mol Microbiol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1017\/S0031182097001133","volume":"114","author":"Nare B.","year":"1997","unstructured":"Nare B.; Luba J.; Hardy L.W.; Beverley S.; New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity. Parasitology 1997,114(Suppl.),S101-S110","journal-title":"Parasitology"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1016\/j.bmcl.2017.06.053","volume":"27","author":"Patil S.R.","year":"2017","unstructured":"Patil S.R.; Asrondkar A.; Patil V.; Sangshetti J.N.; Kalam Khan F.A.; Damale M.G.; Patil R.H.; Bobade A.S.; Shinde D.B.; Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiols: Synthesis, biological evaluations and computational studies. Bioorg Med Chem Lett 2017,27(16),3845-3850","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.bmcl.2014.01.035","volume":"24","author":"Sangshetti J.N.","year":"2014","unstructured":"Sangshetti J.N.; Shaikh R.I.; Khan F.A.K.; Patil R.H.; Marathe S.D.; Gade W.N.; Shinde D.B.; Synthesis, antileishmanial activity and docking study of N\u2032-substitutedbenzylidene-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetohydrazides. Bioorg Med Chem Lett 2014,24(6),1605-1610","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.exppara.2013.07.004","volume":"135","author":"Khademvatan S.","year":"2013","unstructured":"Khademvatan S.; Adibpour N.; Eskandari A.; Rezaee S.; Hashemitabar M.; Rahim F.; \n                        In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes. Exp Parasitol 2013,135(2),208-216","journal-title":"Exp Parasitol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ejmech.2014.12.051","volume":"92","author":"Mendoza-Mart\u00ednez C.","year":"2015","unstructured":"Mendoza-Mart\u00ednez C.; Galindo-Sevilla N.; Correa-Basurto J.; Ugalde-Saldivar V.M.; Rodr\u00edguez-Delgado R.G.; Hern\u00e1ndez-Pineda J.; Padierna-Mota C.; Flores-Alamo M.; Hern\u00e1ndez-Luis F.; Antileishmanial activity of quinazoline derivatives: synthesis, docking screens, molecular dynamic simulations and electrochemical studies. Eur J Med Chem 2015,92,314-331","journal-title":"Eur J Med Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.ejmech.2016.12.019","volume":"126","author":"Taha M.","year":"2017","unstructured":"Taha M.; Ismail N.H.; Imran S.; Anouar E.H.; Selvaraj M.; Jamil W.; Ali M.; Kashif S.M.; Rahim F.; Khan K.M.; Adenan M.I.; Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents. Eur J Med Chem 2017,126,1021-1033","journal-title":"Eur J Med Chem"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejmech.2015.02.038","volume":"94","author":"Bekhit A.A.","year":"2015","unstructured":"Bekhit A.A.; Hassan A.M.M.; Abd El Razik H.A.; El-Miligy M.M.M.; El-Agroudy E.J.; Bekhit, Ael-D. New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents. Eur J Med Chem 2015,94,30-44","journal-title":"Eur J Med Chem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejmech.2017.03.043","volume":"132","author":"Leite F.H.A.","year":"2017","unstructured":"Leite F.H.A.; Froes T.Q.; da Silva S.G.; de Souza E.I.M.; Vital-Fujii D.G.; Trossini G.H.G.; Pita S.S.D.R.; Castilho M.S.; An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. Eur J Med Chem 2017,132,322-332","journal-title":"Eur J Med Chem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1080\/14786419.2015.1126260","volume":"30","author":"Sosa A.M.","year":"2016","unstructured":"Sosa A.M.; Amaya S.; Salamanca Capusiri E.; Gilabert M.; Bard\u00f3n A.; Gim\u00e9nez A.; Vera N.R.; Borkosky S.A.; Active sesquiterpene lactones against Leishmania amazonensis and Leishmania braziliensis. Nat Prod Res 2016,30(22),2611-2615","journal-title":"Nat Prod Res"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/molecules22030426","volume":"22","author":"Di Pisa F.","year":"2017","unstructured":"Di Pisa F.; Landi G.; Dello Iacono L.; Pozzi C.; Borsari C.; Ferrari S.; Santucci M.; Santarem N.; Cordeiro-da-Silva A.; Moraes C.B.; Alcantara L.M.; Fontana V.; Freitas-Junior L.H.; Gul S.; Kuzikov M.; Behrens B.; P\u00f6hner I.; Wade R.C.; Costi M.P.; Mangani S.; Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity. Molecules 2017,22(3),426-441","journal-title":"Molecules"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3390\/molecules22122166","volume":"22","author":"Herrmann F.C.","year":"2017","unstructured":"Herrmann F.C.; Sivakumar N.; Jose J.; Costi M.P.; Pozzi C.; Schmidt T.J.; \n                        In silico identification and in vitro evaluation of natural inhibitors of Leishmania major pteridine reductase I. Molecules 2017,22(12),2166-2179","journal-title":"Molecules"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12639-010-0006-3","volume":"34","author":"Chawla B.","year":"2010","unstructured":"Chawla B.; Madhubala R.; Drug targets in Leishmania. J Parasit Dis 2010,34(1),1-13","journal-title":"J Parasit Dis"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"8318","DOI":"10.1021\/jm300563f","volume":"55","author":"Corona P.","year":"2012","unstructured":"Corona P.; Gibellini F.; Cavalli A.; Saxena P.; Carta A.; Loriga M.; Luciani R.; Paglietti G.; Guerrieri D.; Nerini E.; Gupta S.; Hannaert V.; Michels P.A.M.; Ferrari S.; Costi P.M.; Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors. J Med Chem 2012,55(19),8318-8329","journal-title":"J Med Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"13883","DOI":"10.1074\/jbc.272.21.13883","volume":"272","author":"Nare B.","year":"1997","unstructured":"Nare B.; Hardy L.W.; Beverley S.M.; The roles of pteridine reductase 1 and synthase in pteridine metabolism in the Protozoan parasite Leishmania major. J Biol Chem 1997,272,13883-13891","journal-title":"J Biol Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev.pathol.1.110304.100151","volume":"1","author":"McKerrow J.H.","year":"2006","unstructured":"McKerrow J.H.; Caffrey C.; Kelly B.; Loke P.; Sajid M.; Proteases in parasitic diseases. Annu Rev Pathol 2006,1,497-536","journal-title":"Annu Rev Pathol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-6851(01)00438-8","volume":"120","author":"Sajid M.","year":"2002","unstructured":"Sajid M.; McKerrow J.H.; Cysteine proteases of parasitic organisms. Mol Biochem Parasitol 2002,120(1),1-21","journal-title":"Mol Biochem Parasitol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1515\/znc-2007-5-610","volume":"62","author":"Guedes H.L.","year":"2007","unstructured":"Guedes H.L.; Rezende J.M.; Fonseca M.A.; Salles C.M.; Rossi-Bergmann B.; De-Simone S.G.; Identification of serine proteases from Leishmania braziliensis. Z Natforsch C J Biosci 2007,62(5-6),373-381","journal-title":"Z Natforsch C J Biosci"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00436-007-0706-5","volume":"101","author":"Silva-Lopez R.E.","year":"2007","unstructured":"Silva-Lopez R.E.; Morgado-D\u00edaz J.A.; Ch\u00e1vez M.A.; Giovanni-De-Simone S.; Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes. Parasitol Res 2007,101(6),1627-1635","journal-title":"Parasitol Res"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.molbiopara.2010.09.003","volume":"175","author":"Munday J.C.","year":"2011","unstructured":"Munday J.C.; McLuskey K.; Brown E.; Coombs G.H.; Mottram J.C.; Oligopeptidase B deficient mutants of Leishmania major. Mol Biochem Parasitol 2011,175(1),49-57","journal-title":"Mol Biochem Parasitol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00894-014-2099-6","volume":"20","author":"Goyal S.","year":"2014","unstructured":"Goyal S.; Grover S.; Dhanjal J.K.; Goyal M.; Tyagi C.; Chacko S.; Grover A.; Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis. J Mol Model 2014,20(3),2099-2107","journal-title":"J Mol Model"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1017\/S0031182016002237","volume":"144","author":"Sodero A.C.R.","year":"2017","unstructured":"Sodero A.C.R.; Dos Santos A.C.; Mello J.F.R.; DE Jesus J.B.; DE Souza A.M.; Rodrigues M.I.; DE Simone S.G.; Rodrigues C.R.; DE Matos Guedes H.L.; Oligopeptidase B and B2: comparative modelling and virtual screening as searching tools for new antileishmanial compounds. Parasitology 2017,144(4),536-545","journal-title":"Parasitology"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1016\/j.bmcl.2015.06.085","volume":"25","author":"Passalacqua T.G.","year":"2015","unstructured":"Passalacqua T.G.; Torres F.A.E.; Nogueira C.T.; de Almeida L.; Del Cistia M.L.; dos Santos M.B.; Dutra L.A.; Bolzani V.S.; Regasini L.O.; Graminha M.A.; Marchetto R.; Zottis A.; The 2\u2032,4\u2032-dihydroxychalcone could be explored to develop new inhibitors against the glycerol-3-phosphate dehydrogenase from Leishmania species. Bioorg Med Chem Lett 2015,25(17),3564-3568","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6807-9-9","volume":"9","author":"Cook W.J.","year":"2009","unstructured":"Cook W.J.; Senkovich O.; Chattopadhyay D.; An unexpected phosphate binding site in glyceraldehyde 3-phosphate dehydrogenase: crystal structures of apo, holo and ternary complex of Cryptosporidium parvum enzyme. BMC Struct Biol 2009,9,9-22","journal-title":"BMC Struct Biol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.3390\/molecules18055032","volume":"18","author":"Lozano N.B.H.","year":"2013","unstructured":"Lozano N.B.H.; Oliveira R.F.; Weber K.C.; Honorio K.M.; Guido R.V.; Andricopulo A.D.; Da Silva A.B.F.; Identification of electronic and structural descriptors of adenosine analogues related to inhibition of leishmanial glyceraldehyde-3-phosphate dehydrogenase. Molecules 2013,18(5),5032-5050","journal-title":"Molecules"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"14975","DOI":"10.1021\/bi00046a004","volume":"34","author":"Kim H.","year":"1995","unstructured":"Kim H.; Feil I.K.; Verlinde C.L.; Petra P.H.; Hol W.G.; Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding site. Biochemistry 1995,34(46),14975-14986","journal-title":"Biochemistry"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2015.06.014","volume":"101","author":"da Matta C.B.B.","year":"2015","unstructured":"da Matta C.B.B.; de Queiroz A.C.; Santos M.S.; Alexandre-Moreira M.S.; Gon\u00e7alves V.T.; Del Cistia, Cde.N.; Sant\u2019Anna, C.M.R.; DaCosta, J.B.N. Novel dialkylphosphorylhydrazones: Synthesis, leishmanicidal evaluation and theoretical investigation of the proposed mechanism of action. Eur J Med Chem 2015,101,1-12","journal-title":"Eur J Med Chem"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1054\/drup.2000.0177","volume":"4","author":"Verlinde C.L.","year":"2001","unstructured":"Verlinde C.L.; Hannaert V.; Blonski C.; Willson M.; P\u00e9ri\u00e9 J.J.; Fothergill-Gilmore L.A.; Opperdoes F.R.; Gelb M.H.; Hol W.G.; Michels P.A.; Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Updat 2001,4(1),50-65","journal-title":"Drug Resist Updat"},{"key":"ref=156","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/965725","volume":"2015","author":"Silva L.A.","year":"2015","unstructured":"Silva L.A.; Vinaud M.C.; Castro A.M.; Cravo P.V.L.; Bezerra J.C.B.; \n                        In silico search of energy metabolism inhibitors for alternative leishmaniasis treatments. BioMed Res Int 2015,2015","journal-title":"BioMed Res Int"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1021\/jm000472o","volume":"44","author":"Bressi J.C.","year":"2001","unstructured":"Bressi J.C.; Verlinde C.L.; Aronov A.M.; Shaw M.L.; Shin S.S.; Nguyen L.N.; Suresh S.; Buckner F.S.; Van Voorhis W.C.; Kuntz I.D.; Hol W.G.J.; Gelb M.H.; Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J Med Chem 2001,44(13),2080-2093","journal-title":"J Med Chem"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.bbabio.2012.09.008","volume":"1827","author":"Iverson T.M.","year":"2013","unstructured":"Iverson T.M.; Catalytic mechanisms of complex II enzymes: a structural perspective. Biochim Biophys Acta 2013,1827(5),648-657","journal-title":"Biochim Biophys Acta"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jmgm.2013.12.001","volume":"48","author":"Merlino A.","year":"2014","unstructured":"Merlino A.; Vieites M.; Gambino D.; Coiti\u00f1o E.L.; Homology modeling of T. cruzi and L. major NADH-dependent fumarate reductases: ligand docking, molecular dynamics validation, and insights on their binding modes. J Mol Graph Model 2014,48,47-59","journal-title":"J Mol Graph Model"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0304-4165(78)90104-6","volume":"544","author":"Marr J.J.","year":"1978","unstructured":"Marr J.J.; Berens R.L.; Nelson D.J.; Purine metabolism in Leishmania donovani and Leishmania braziliansis. Biochim. Biophys. Acta (BBA) -. Gen Subj 1978,544,360-371","journal-title":"Gen Subj"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijbiomac.2015.11.051","volume":"83","author":"Ansari M.Y.","year":"2016","unstructured":"Ansari M.Y.; Equbal A.; Dikhit M.R.; Mansuri R.; Rana S.; Ali V.; Sahoo G.C.; Das P.; Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors. Int J Biol Macromol 2016,83,78-96","journal-title":"Int J Biol Macromol"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1074\/jbc.273.3.1534","volume":"273","author":"Shih S.","year":"1998","unstructured":"Shih S.; Hwang H-Y.; Carter D.; Stenberg P.; Ullman B.; Localization and targeting of the Leishmania donovani hypoxanthine-guanine phosphoribosyltransferase to the glycosome. J Biol Chem 1998,273(3),1534-1541","journal-title":"J Biol Chem"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s00018-008-8123-1","volume":"65","author":"Park J.","year":"2008","unstructured":"Park J.; Gupta R.S.; Adenosine kinase and ribokinase--the RK family of proteins. Cell Mol Life Sci 2008,65(18),2875-2896","journal-title":"Cell Mol Life Sci"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/978-0-387-77570-8_10","volume":"625","author":"Datta A.K.","year":"2008","unstructured":"Datta A.K.; Datta R.; Sen B.; Antiparasitic chemotherapy: tinkering with the purine salvage pathway. Adv Exp Med Biol 2008,625,116-132","journal-title":"Adv Exp Med Biol"},{"key":"ref=165","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/609289","volume":"2013609289","author":"Kar R.K.","year":"2013","unstructured":"Kar R.K.; Ansari M.Y.; Suryadevara P.; Sahoo B.R.; Sahoo G.C.; Dikhit M.R.; Das P.; Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase. BioMed Res Int 2013,2013609289","journal-title":"BioMed Res Int"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1039\/c0mb00307g","volume":"7","author":"Souza T.A.C.B.","year":"2011","unstructured":"Souza T.A.C.B.; Trindade D.M.; Tonoli C.C.C.; Santos C.R.; Ward R.J.; Arni R.K.; Oliveira A.H.C.; Murakami M.T.; Molecular adaptability of nucleoside diphosphate kinase b from trypanosomatid parasites: stability, oligomerization and structural determinants of nucleotide binding. Mol Biosyst 2011,7(7),2189-2195","journal-title":"Mol Biosyst"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0305-0491(73)90070-9","volume":"45","author":"Parks R.E.","year":"1973","unstructured":"Parks R.E.; Brown P.R.; Cheng Y.C.; Agarwal K.C.; Kong C.M.; Agarwal R.P.; Parks C.C.; Purine metabolism in primitive erythrocytes. Comp Biochem Physiol B 1973,45(2),355-364","journal-title":"Comp Biochem Physiol B"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(SICI)1097-4652(200002)182:2<144:AID-JCP2>3.0.CO;2-6","volume":"182","author":"Lombardi D.","year":"2000","unstructured":"Lombardi D.; Lacombe M.L.; Paggi M.G.; nm23: unraveling its biological function in cell differentiation. J Cell Physiol 2000,182(2),144-149","journal-title":"J Cell Physiol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1005584929050","volume":"32","author":"Lacombe M.L.","year":"2000","unstructured":"Lacombe M.L.; Milon L.; Munier A.; Mehus J.G.; Lambeth D.O.; The human Nm23\/nucleoside diphosphate kinases. J Bioenerg Biomembr 2000,32(3),247-258","journal-title":"J Bioenerg Biomembr"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2958.1996.tb02538.x","volume":"20","author":"Sundin G.W.","year":"1996","unstructured":"Sundin G.W.; Shankar S.; Chugani S.A.; Chopade B.A.; Kavanaugh-Black A.; Chakrabarty A.M.; Nucleoside diphosphate kinase from Pseudomonas aeruginosa: characterization of the gene and its role in cellular growth and exopolysaccharide alginate synthesis. Mol Microbiol 1996,20(5),965-979","journal-title":"Mol Microbiol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10822-017-0022-9","volume":"31","author":"Mishra A.K.","year":"2017","unstructured":"Mishra A.K.; Singh N.; Agnihotri P.; Mishra S.; Singh S.P.; Kolli B.K.; Chang K.P.; Sahasrabuddhe A.A.; Siddiqi M.I.; Pratap J.V.; Discovery of novel inhibitors for Leishmania nucleoside diphosphatase kinase (NDK) based on its structural and functional characterization. J Comput Aided Mol Des 2017,31(6),547-562","journal-title":"J Comput Aided Mol Des"},{"key":"ref=172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003588","volume":"9","author":"McCall L-I.","year":"2015","unstructured":"McCall L-I.; El Aroussi A.; Choi J.Y.; Vieira D.F.; De Muylder G.; Johnston J.B.; Chen S.; Kellar D.; Siqueira-Neto J.L.; Roush W.R.; Podust L.M.; McKerrow J.H.; Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase. PLoS Negl Trop Dis 2015,9(3)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/2193-1801-3-679","volume":"3","author":"Warfield J.","year":"2014","unstructured":"Warfield J.; Setzer W.N.; Ogungbe I.V.; Interactions of antiparasitic sterols with sterol 14\u03b1-demethylase (CYP51) of human pathogens. Springerplus 2014,3,679-689","journal-title":"Springerplus"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1194\/jlr.M021865","volume":"53","author":"Hargrove T.Y.","year":"2012","unstructured":"Hargrove T.Y.; Wawrzak Z.; Liu J.; Waterman M.R.; Nes W.D.; Lepesheva G.I.; Structural complex of sterol 14\u03b1-demethylase (CYP51) with 14\u03b1-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol. J Lipid Res 2012,53(2),311-320","journal-title":"J Lipid Res"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.parint.2016.01.001","volume":"65","author":"Melo T.S.","year":"2016","unstructured":"Melo T.S.; Gattass C.R.; Soares D.C.; Cunha M.R.; Ferreira C.; Tavares M.T.; Saraiva E.; Parise-Filho R.; Braden H.; Delorenzi J.C.; Oleanolic acid (OA) as an antileishmanial agent: Biological evaluation and in silico mechanistic insights. Parasitol Int 2016,65(3),227-237","journal-title":"Parasitol Int"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.4155\/fmc.13.114","volume":"5","author":"Ogungbe I.V.","year":"2013","unstructured":"Ogungbe I.V.; Ng J.D.; Setzer W.N.; Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis. Future Med Chem 2013,5(15),1777-1799","journal-title":"Future Med Chem"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1107\/S1744309112019124","volume":"68","author":"Fyfe P.K.","year":"2012","unstructured":"Fyfe P.K.; Westrop G.D.; Ramos T.; M\u00fcller S.; Coombs G.H.; Hunter W.N.; Structure of Leishmania major cysteine synthase. Acta Crystallogr Sect F Struct Biol Cryst Commun 2012,68(Pt 7),738-743","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.molbiopara.2009.04.009","volume":"167","author":"Caffrey C.R.","year":"2009","unstructured":"Caffrey C.R.; Steverding D.; Kinetoplastid papain-like cysteine peptidases. Mol Biochem Parasitol 2009,167(1),12-19","journal-title":"Mol Biochem Parasitol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.bmcl.2017.04.010","volume":"27","author":"Gomes M.N.","year":"2017","unstructured":"Gomes M.N.; Alc\u00e2ntara L.M.; Neves B.J.; Melo-Filho C.C.; Freitas-Junior L.H.; Moraes C.B.; Ma R.; Franzblau S.G.; Muratov E.; Andrade C.H.; Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum. Bioorg Med Chem Lett 2017,27(11),2459-2464","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.ijpara.2007.03.008","volume":"37","author":"Besteiro S.","year":"2007","unstructured":"Besteiro S.; Williams R.A.; Coombs G.H.; Mottram J.C.; Protein turnover and differentiation in Leishmania. Int J Parasitol 2007,37(10),1063-1075","journal-title":"Int J Parasitol"},{"key":"ref=182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077460","volume":"8","author":"Schr\u00f6der J.","year":"2013","unstructured":"Schr\u00f6der J.; Noack S.; Marh\u00f6fer R.J.; Mottram J.C.; Coombs G.H.; Selzer P.M.; Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB. PLoS One 2013,8(10)","journal-title":"PLoS One"},{"key":"ref=183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000555","volume":"5","author":"Rogers M.","year":"2009","unstructured":"Rogers M.; Kropf P.; Choi B.S.; Dillon R.; Podinovskaia M.; Bates P.; M\u00fcller I.; Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival. PLoS Pathog 2009,5(8)","journal-title":"PLoS Pathog"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-94-007-7305-9_4","volume":"74","author":"da Silva M.F.","year":"2014","unstructured":"da Silva M.F.; Floeter-Winter L.M.; Arginase in Leishmania. Subcell Biochem 2014,74,103-117","journal-title":"Subcell Biochem"},{"key":"ref=185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078387","volume":"8","author":"dos Reis M.B.","year":"2013","unstructured":"dos Reis M.B.; Manjolin L.C.; Maquiaveli, Cdo.C.; Santos-Filho, O.A.; da Silva, E.R. Inhibition of Leishmania (Leishmania) amazonensis and rat arginases by green tea EGCG, (+)-catechin and (-)-epicatechin: a comparative structural analysis of enzyme-inhibitor interactions. PLoS One 2013,8(11)","journal-title":"PLoS One"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molbiopara.2009.01.001","volume":"165","author":"Reguera R.M.","year":"2009","unstructured":"Reguera R.M.; Bala\u00f1a-Fouce R.; Showalter M.; Hickerson S.; Beverley S.M.; \n                        Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB\/c mice. Mol Biochem Parasitol 2009,165(1),48-56","journal-title":"Mol Biochem Parasitol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0020-7519(02)00002-4","volume":"32","author":"da Silva E.R.","year":"2002","unstructured":"da Silva E.R.; Castilho T.M.; Pioker F.C.; Tomich de Paula Silva C.H.; Floeter-Winter L.M.; Genomic organisation and transcription characterisation of the gene encoding Leishmania (Leishmania) amazonensis arginase and its protein structure prediction. Int J Parasitol 2002,32(6),727-737","journal-title":"Int J Parasitol"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/20477724.2017.1312777","volume":"111","author":"Adinehbeigi K.","year":"2017","unstructured":"Adinehbeigi K.; Razi Jalali M.H.; Shahriari A.; Bahrami S.; \n                        In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum. Pathog Glob Health 2017,111(4),176-185","journal-title":"Pathog Glob Health"},{"key":"ref=189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000675","volume":"4","author":"Siqueira-Neto J.L.","year":"2010","unstructured":"Siqueira-Neto J.L.; Song O.R.; Oh H.; Sohn J.H.; Yang G.; Nam J.; Jang J.; Cechetto J.; Lee C.B.; Moon S.; Genovesio A.; Chatelain E.; Christophe T.; Freitas-Junior L.H.; Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds. PLoS Negl Trop Dis 2010,4(5)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.abb.2008.11.003","volume":"481","author":"Nes W.D.","year":"2009","unstructured":"Nes W.D.; Zhou W.; Ganapathy K.; Liu J.; Vatsyayan R.; Chamala S.; Hernandez K.; Miranda M.; Sterol 24-C-methyltransferase: an enzymatic target for the disruption of ergosterol biosynthesis and homeostasis in Cryptococcus neoformans. Arch Biochem Biophys 2009,481(2),210-218","journal-title":"Arch Biochem Biophys"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1128\/AAC.48.8.2937-2950.2004","volume":"48","author":"Lorente S.O.","year":"2004","unstructured":"Lorente S.O.; Rodrigues J.C.; Jim\u00e9nez Jim\u00e9nez C.; Joyce-Menekse M.; Rodrigues C.; Croft S.L.; Yardley V.; de Luca-Fradley K.; Ruiz-P\u00e9rez L.M.; Urbina J.; de Souza W.; Gonz\u00e1lez Pacanowska D.; Gilbert I.H.; Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis. Antimicrob Agents Chemother 2004,48(8),2937-2950","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1007\/s11033-014-3299-y","volume":"41","author":"Azam S.S.","year":"2014","unstructured":"Azam S.S.; Abro A.; Raza S.; Saroosh A.; Structure and dynamics studies of sterol 24-C-methyltransferase with mechanism based inactivators for the disruption of ergosterol biosynthesis. Mol Biol Rep 2014,41(7),4279-4293","journal-title":"Mol Biol Rep"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1080\/07391102.2014.1002423","volume":"33","author":"Azam S.S.","year":"2015","unstructured":"Azam S.S.; Abro A.; Raza S.; Binding pattern analysis and structural insight into the inhibition mechanism of Sterol 24-C methyltransferase by docking and molecular dynamics approach. J Biomol Struct Dyn 2015,33(12),2563-2577","journal-title":"J Biomol Struct Dyn"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0166-6851(01)00220-1","volume":"113","author":"Hassan P.","year":"2001","unstructured":"Hassan P.; Fergusson D.; Grant K.M.; Mottram J.C.; The CRK3 protein kinase is essential for cell cycle progression of Leishmania mexicana. Mol Biochem Parasitol 2001,113(2),189-198","journal-title":"Mol Biochem Parasitol"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/expr.1996.0012","volume":"82","author":"Li S.","year":"1996","unstructured":"Li S.; Wilson M.E.; Donelson J.E.; \n                        Leishmania chagasi: a gene encoding a protein kinase with a catalytic domain structurally related to MAP kinase kinase. Exp Parasitol 1996,82(2),87-96","journal-title":"Exp Parasitol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-9292-4-6","volume":"4","author":"Wang Q.","year":"2005","unstructured":"Wang Q.; Melzer I.M.; Kruse M.; Sander-Juelch C.; Wiese M.; LmxMPK4, a mitogen-activated protein (MAP) kinase homologue essential for promastigotes and amastigotes of Leishmania mexicana. Kinetoplastid Biol Dis 2005,4,6-14","journal-title":"Kinetoplastid Biol Dis"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ijpara.2007.04.008","volume":"37","author":"Wiese M.","year":"2007","unstructured":"Wiese M.; \n                        Leishmania MAP kinases--familiar proteins in an unusual context. Int J Parasitol 2007,37(10),1053-1062","journal-title":"Int J Parasitol"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12539-013-0164-y","volume":"5","author":"Gupta C.L.","year":"2013","unstructured":"Gupta C.L.; Khan M.K.A.; Khan M.F.; Tiwari A.K.; Homology modeling of LmxMPK4 of Leishmania mexicana and virtual screening of potent inhibitors against it. Interdiscip Sci 2013,5(2),136-144","journal-title":"Interdiscip Sci"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12539-015-0269-6","volume":"8","author":"Gupta C.L.","year":"2016","unstructured":"Gupta C.L.; Akhtar S.; Kumar N.; Ali J.; Pathak N.; Bajpai P.; \n                        In silico elucidation and inhibition studies of selected phytoligands against mitogen-activated protein kinases of protozoan parasites. Interdiscip Sci 2016,8(1),41-52","journal-title":"Interdiscip Sci"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","volume":"65","author":"Wang J.C.","year":"1996","unstructured":"Wang J.C.; DNA topoisomerases. Annu Rev Biochem 1996,65,635-692","journal-title":"Annu Rev Biochem"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.pt.2004.06.005","volume":"20","author":"Das A.","year":"2004","unstructured":"Das A.; Dasgupta A.; Sengupta T.; Majumder H.K.; Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets. Trends Parasitol 2004,20(8),381-387","journal-title":"Trends Parasitol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1128\/AAC.00352-16","volume":"60","author":"Saha S.","year":"2016","unstructured":"Saha S.; Acharya C.; Pal U.; Chowdhury S.R.; Sarkar K.; Maiti N.C.; Jaisankar P.; Majumder H.K.; A novel spirooxindole derivative inhibits the growth of Leishmania donovani parasites both in vitro and in vivo by targeting type IB topoisomerase. Antimicrob Agents Chemother 2016,60(10),6281-6293","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"Ferreira L.G.","year":"2015","unstructured":"Ferreira L.G.; Dos Santos R.N.; Oliva G.; Andricopulo A.D.; Molecular docking and structure-based drug design strategies. Molecules 2015,20(7),13384-13421","journal-title":"Molecules"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/B978-0-12-802508-6.00027-2","author":"Berry M.","year":"2015","unstructured":"Berry M.; Fielding B.; Gamieldien J.;  Emerging\nTrends in Computational Biology, Bioinformatics, and Systems\nBiology 2015,487-502","journal-title":"Emerging\nTrends in Computational Biology, Bioinformatics, and Systems\nBiology"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jmr.2471","volume":"28","author":"Yuriev E.","year":"2015","unstructured":"Yuriev E.; Holien J.; Ramsland P.A.; Improvements, trends, and new ideas in molecular docking: 2012-2013 in review. J Mol Recognit 2015,28(10),581-604","journal-title":"J Mol Recognit"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/AABC.S105289","volume":"9","author":"de Ruyck J.","year":"2016","unstructured":"de Ruyck J.; Brysbaert G.; Blossey R.; Lensink M.F.; Molecular docking as a popular tool in drug design, an in silico travel. Adv Appl Bioinform Chem 2016,9,1-11","journal-title":"Adv Appl Bioinform Chem"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/cmdc.201500385","volume":"11","author":"Aguilera E.","year":"2016","unstructured":"Aguilera E.; Varela J.; Birriel E.; Serna E.; Torres S.; Yaluff G.; de Bilbao N.V.; Aguirre-L\u00f3pez B.; Cabrera N.; D\u00edaz Mazariegos S.; de G\u00f3mez-Puyou M.T.; G\u00f3mez-Puyou A.; P\u00e9rez-Montfort R.; Minini L.; Merlino A.; Cerecetto H.; Gonz\u00e1lez M.; Alvarez G.; Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity. ChemMedChem 2016,11(12),1328-1338","journal-title":"ChemMedChem"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.drudis.2015.02.004","volume":"20","author":"Martinez-Mayorga K.","year":"2015","unstructured":"Martinez-Mayorga K.; Byler K.G.; Ramirez-Hernandez A.I.; Terrazas-Alvares D.E.; Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits. Drug Discov Today 2015,20(7),890-898","journal-title":"Drug Discov Today"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1080\/07391102.2016.1176603","volume":"35","author":"Vital D.G.","year":"2017","unstructured":"Vital D.G.; Damasceno F.S.; Rapado L.N.; Silber A.M.; Vilella F.S.; Ferreira R.S.; Maltarollo V.G.; Trossini G.H.; Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study. J Biomol Struct Dyn 2017,35(6),1244-1259","journal-title":"J Biomol Struct Dyn"},{"key":"ref=210","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1016\/j.bmc.2016.07.013","volume":"24","author":"Silva-J\u00fanior E.F.","year":"2016","unstructured":"Silva-J\u00fanior E.F.; Silva E.P.S.; Fran\u00e7a P.H.B.; Silva J.P.N.; Barreto E.O.; Silva E.B.; Ferreira R.S.; Gatto C.C.; Moreira D.R.M.; Siqueira-Neto J.L.; Mendon\u00e7a-Junior F.J.B.; Lima M.C.A.; Bortoluzzi J.H.; Scotti M.T.; Scotti L.; Meneghetti M.R.; Aquino T.M.; Ara\u00fajo-J\u00fanior J.X.; Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi. Bioorg Med Chem 2016,24,4228-4240","journal-title":"Bioorg Med Chem"},{"key":"ref=211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157340991301170127200639","volume":"13","author":"Silva-J\u00fanior E.F.","year":"2017","unstructured":"Silva-J\u00fanior E.F.; Fran\u00e7a P.H.B.; Ribeiro F.F.; Mendon\u00e7a-Junior F.J.B.; Scotti M.T.; Scotti L.; Aquino T.M.; Ara\u00fajo-J\u00fanior J.X.; Molecular Docking Studies Applied to a Dataset of Cruzain Inhibitors. Curr Comp Aided Drug Des 2017,13,1-8","journal-title":"Curr Comp Aided Drug Des"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4155\/fmc-2016-0236","volume":"9","author":"Pauli I.","year":"2017","unstructured":"Pauli I.; Ferreira L.G.; de Souza M.L.; Oliva G.; Ferreira R.S.; Dessoy M.A.; Slafer B.W.; Dias L.C.; Andricopulo A.D.; Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors. Future Med Chem 2017,9(7),641-657","journal-title":"Future Med Chem"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10822-017-0039-0","volume":"31","author":"de Souza A.S.","year":"2017","unstructured":"de Souza A.S.; de Oliveira M.T.; Andricopulo A.D.; Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure-activity relationship studies. J Comput Aided Mol Des 2017,31(9),801-816","journal-title":"J Comput Aided Mol Des"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2174\/1573406412666160701022230","volume":"13","author":"Elizondo-Jimenez S.","year":"2017","unstructured":"Elizondo-Jimenez S.; Moreno-Herrera A.; Reyes-Olivares R.; Dorantes-Gonzalez E.; Nogueda-Torres B.; Oliveira E.A.G.; Romeiro N.C.; Lima L.M.; Palos I.; Rivera G.; Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents. Med Chem 2017,13(2),149-158","journal-title":"Med Chem"},{"key":"ref=215","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003773","volume":"9","author":"Beig M.","year":"2015","unstructured":"Beig M.; Oellien F.; Garoff L.; Noack S.; Krauth-Siegel R.L.; Selzer P.M.; Trypanothione reductase: a target protein for a combined in vitro and in silico screening approach. PLoS Negl Trop Dis 2015,9(6)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.compbiolchem.2016.10.002","volume":"65","author":"Hossain M.U.","year":"2016","unstructured":"Hossain M.U.; Oany A.R.; Ahmad S.A.I.; Hasan M.A.; Khan M.A.; Siddikey M.A.A.; Identification of potential inhibitor and enzyme-inhibitor complex on trypanothione reductase to control Chagas disease. Comput Biol Chem 2016,65,29-36","journal-title":"Comput Biol Chem"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00894-016-3115-9","volume":"22","author":"Lima C.R.","year":"2016","unstructured":"Lima C.R.; Carels N.; Guimaraes A.C.; Tuff\u00e9ry P.; Derreumaux P.; \n                        In silico structural characterization of protein targets for drug development against Trypanosoma cruzi. J Mol Model 2016,22(10),244-258","journal-title":"J Mol Model"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ejmech.2016.10.055","volume":"125","author":"Arias D.G.","year":"2017","unstructured":"Arias D.G.; Herrera F.E.; Garay A.S.; Rodrigues D.; Forastieri P.S.; Luna L.E.; B\u00fcrgi M.D.; Prieto C.; Iglesias A.A.; Cravero R.M.; Guerrero S.A.; Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase. Eur J Med Chem 2017,125,1088-1097","journal-title":"Eur J Med Chem"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jmgm.2015.02.002","volume":"58","author":"Minini L.","year":"2015","unstructured":"Minini L.; \u00c1lvarez G.; Gonz\u00e1lez M.; Cerecetto H.; Merlino A.; Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity. J Mol Graph Model 2015,58,40-49","journal-title":"J Mol Graph Model"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/molecules21030368","volume":"21","author":"Ortiz C.","year":"2016","unstructured":"Ortiz C.; Moraca F.; Medeiros A.; Botta M.; Hamilton N.; Comini M.A.; Binding Mode and Selectivity of Steroids towards Glucose-6-phosphate Dehydrogenase from the Pathogen Trypanosoma cruzi. Molecules 2016,21(3),368","journal-title":"Molecules"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jmgm.2017.08.007","volume":"77","author":"de V C Sinatti V.","year":"2017","unstructured":"de V C Sinatti V.; R Baptista L.P.; Alves-Ferreira M.; Dardenne L.; Herm\u00ednio Martins da Silva J.; Guimar\u00e3es A.C..; In silico identification of inhibitors of ribose 5-phosphate isomerase from Trypanosoma cruzi using ligand and structure based approaches. J Mol Graph Model 2017,77,168-180","journal-title":"J Mol Graph Model"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/07391102.2015.1038584","volume":"34","author":"Carraro R.","year":"2016","unstructured":"Carraro R.; Iribarne F.; Paulino M.; Analysis of cyclosporin A and a set of analogs as inhibitors of a T. cruzi cyclophilin by docking and molecular dynamics. J Biomol Struct Dyn 2016,34(2),399-413","journal-title":"J Biomol Struct Dyn"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s10822-016-9985-1","volume":"30","author":"de Almeida H.","year":"2016","unstructured":"de Almeida H.; Leroux V.; Motta F.N.; Grellier P.; Maigret B.; Santana J.M.; Bastos I.M.; Identification of novel Trypanosoma cruzi prolyl oligopeptidase inhibitors by structure-based virtual screening. J Comput Aided Mol Des 2016,30(12),1165-1174","journal-title":"J Comput Aided Mol Des"},{"key":"ref=224","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158434","volume":"11","author":"Nordvang R.T.","year":"2016","unstructured":"Nordvang R.T.; Nyffenegger C.; Holck J.; Jers C.; Zeuner B.; Sundekilde U.K.; Meyer A.S.; Mikkelsen J.D.; It All Starts with a Sandwich: Identification of Sialidases with Trans-Glycosylation Activity. PLoS One 2016,11(7)","journal-title":"PLoS One"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1038\/s41598-017-06411-9","volume":"7","author":"Yoshino R.","year":"2017","unstructured":"Yoshino R.; Yasuo N.; Hagiwara Y.; Ishida T.; Inaoka D.K.; Amano Y.; Tateishi Y.; Ohno K.; Namatame I.; Niimi T.; Orita M.; Kita K.; Akiyama Y.; Sekijima M.; \n                        In silico, in vitro, X-ray crystallography, and integrated strategies for discovering spermidine synthase inhibitors for Chagas disease. Sci Rep 2017,7(1),6666","journal-title":"Sci Rep"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules21101389","volume":"21","author":"Ogungbe I.V.","year":"2016","unstructured":"Ogungbe I.V.; Setzer W.N.; The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases-Part III: In-silico molecular docking investigations. Molecules 2016,21(10),1-48","journal-title":"Molecules"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12539-011-0101-x","volume":"3","author":"Venkatesan S.K.","year":"2011","unstructured":"Venkatesan S.K.; Saudagar P.; Shukla A.K.; Dubey V.K.; Screening natural products database for identification of potential antileishmanial chemotherapeutic agents. Interdiscip Sci 2011,3(3),217-231","journal-title":"Interdiscip Sci"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"PA12","DOI":"10.1055\/s-0033-1351916","volume":"79","author":"Herrmann F.C.","year":"2013","unstructured":"Herrmann F.C.; Schmidt T.J.; \n                        In silico screening of natural product databases reveals new potential leads against neglected diseases. Planta Med 2013,79,PA12","journal-title":"Planta Med"},{"key":"ref=229","unstructured":"Natural Products Alert, Available at: Napralert.","journal-title":"Natural Products Alert, Available at:"},{"key":"ref=230","author":"Buckingham J.","year":"2016","unstructured":"Buckingham J.;  Dictionary of Natural Products on DVD 2016","journal-title":"Dictionary of Natural Products on DVD"},{"key":"ref=231","unstructured":"Bioinformatics and Chemical Informatics Research\nCenter, Department of Pharmaceutical Chemistry, University\nof California: San Francisco, CA. USA Available at: ZINC.","journal-title":"USA Available at:"},{"key":"ref=232","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23010103","volume":"23","author":"Scotti M.T.","year":"2018","unstructured":"Scotti M.T.; Herrera-Acevedo C.; Oliveira T.B.; Costa R.P.O.; Santos S.Y.K.O.; Rodrigues R.P.; Scotti L.; Da-Costa F.B.; SistematX, an online web-based cheminformatics tool for data management of secondary metabolites. Molecules 2018,23(1)","journal-title":"Molecules"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1039\/c0np00069h","volume":"28","author":"Izumi E.","year":"2011","unstructured":"Izumi E.; Ueda-Nakamura T.; Dias Filho B.P.; Veiga J\u00fanior V.F.; Nakamura C.V.; Natural products and Chagas\u2019 disease: a review of plant compounds studied for activity against Trypanosoma cruzi. Nat Prod Rep 2011,28(4),809-823","journal-title":"Nat Prod Rep"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/157488470903140806114147","volume":"9","author":"McCulley S.F.","year":"2014","unstructured":"McCulley S.F.; Setzer W.N.; An in-silico investigation of anti-Chagas phytochemicals. Curr Clin Pharmacol 2014,9(3),205-257","journal-title":"Curr Clin Pharmacol"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/1934578X1501000630","volume":"10","author":"Ribeiro F.F.","year":"2015","unstructured":"Ribeiro F.F.; Junior F.J.B.M.; da Silva M.S.; Scotti M.T.; Scotti L.; Computational and investigative study of flavonoids against Trypanosoma cruzi and Leishmania spp. Nat Prod Commun 2015,10(6),917-920","journal-title":"Nat Prod Commun"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1934578X1601100118","volume":"11","author":"Arg\u00fcelles A.J.","year":"2016","unstructured":"Arg\u00fcelles A.J.; Cordell G.A.; Maruenda H.; Molecular docking and binding mode analysis of plant alkaloids as in vitro and in silico inhibitors of trypanothione reductase from Trypanosoma cruzi. Nat Prod Commun 2016,11(1),57-62","journal-title":"Nat Prod Commun"},{"key":"ref=237","first-page":"247","volume":"6","author":"Asthana S.","year":"2014","unstructured":"Asthana S.; Agarwal T.; Banerjee I.; Ray S.S.; \n                        In silico screening to elucidate the therapeutic potentials of asparagamine A. Int J Pharm Pharm Sci 2014,6,247-253","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00044-014-1122-x","volume":"24","author":"Saha D.","year":"2015","unstructured":"Saha D.; Sharma A.; Docking-based screening of natural product database in quest for dual site inhibitors of Trypanosoma cruzi trypanothione reductase (TcTR). Med Chem Res 2015,24,316-333","journal-title":"Med Chem Res"},{"key":"ref=239","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22010079","volume":"22","author":"Herrera Acevedo C.","year":"2017","unstructured":"Herrera Acevedo C.; Scotti L.; Feitosa Alves M.; Formiga Melo Diniz M.F.; Scotti M.T.; Computer-aided drug design using sesquiterpene lactones as sources of new structures with potential activity against infectious neglected diseases. Molecules 2017,22(1)","journal-title":"Molecules"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2174\/13895575113139990066","volume":"13","author":"Fabian L.","year":"2013","unstructured":"Fabian L.; Sulsen V.; Frank F.; Cazorla S.; Malchiodi E.; Martino V.; Lizarraga E.; Catal\u00e1n C.; Moglioni A.; Muschietti L.; Finkielsztein L.; \n                        In silico study of structural and geometrical requirements of natural sesquiterpene lactones with trypanocidal activity. Mini Rev Med Chem 2013,13(10),1407-1414","journal-title":"Mini Rev Med Chem"},{"key":"ref=241","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002689","volume":"8","author":"Sacconnay L.","year":"2014","unstructured":"Sacconnay L.; Angleviel M.; Randazzo G.M.; Queiroz M.M.; Queiroz E.F.; Wolfender J-L.; Carrupt P-A.; Nurisso A.; Computational studies on sirtuins from Trypanosoma cruzi: structures, conformations and interactions with phytochemicals. PLoS Negl Trop Dis 2014,8(2)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"Irwin J.J.","year":"2005","unstructured":"Irwin J.J.; Shoichet B.K.; ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005,45(1),177-182","journal-title":"J Chem Inf Model"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jmgm.2014.11.002","volume":"55","author":"Capriles P.V.","year":"2015","unstructured":"Capriles P.V.; Baptista L.P.; Guedes I.A.; Guimar\u00e3es A.C.; Cust\u00f3dio F.L.; Alves-Ferreira M.; Dardenne L.E.; Structural modeling and docking studies of ribose 5-phosphate isomerase from Leishmania major and Homo sapiens: a comparative analysis for Leishmaniasis treatment. J Mol Graph Model 2015,55,134-147","journal-title":"J Mol Graph Model"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1021\/ci300400a","volume":"52","author":"Xu C.","year":"2012","unstructured":"Xu C.; Cheng F.; Chen L.; Du Z.; Li W.; Liu G.; Lee P.W.; Tang Y.; \n                        In silico prediction of chemical Ames mutagenicity. J Chem Inf Model 2012,52(11),2840-2847","journal-title":"J Chem Inf Model"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"Baell J.B.","year":"2010","unstructured":"Baell J.B.; Holloway G.A.; New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 2010,53(7),2719-2740","journal-title":"J Med Chem"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4155\/fmc.11.44","volume":"3","author":"Whitty A.","year":"2011","unstructured":"Whitty A.; Growing PAINS in academic drug discovery. Future Med Chem 2011,3(7),797-801","journal-title":"Future Med Chem"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/DDDT.S120618","volume":"11","author":"da Silva C.F.","year":"2017","unstructured":"da Silva C.F.; Batista D.D.G.J.; de Ara\u00fajo J.S.; Cunha-Junior E.F.; Stephens C.E.; Banerjee M.; Farahat A.A.; Akay S.; Fisher M.K.; Boykin D.W.; Soeiro M.N.C.; Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection. Drug Des Devel Ther 2017,11,1095-1105","journal-title":"Drug Des Devel Ther"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1017\/S0031182011001429","volume":"138","author":"D.A. Silva C.F.","year":"2011","unstructured":"D.A. Silva C.F.; Daliry, A.; DA Silva, P.B.; Akay, S.; Banerjee, M.; Farahat, A.A.; Fisher, M.K.; Hu, L.; Kumar, A.; Liu, Z.; Stephens, C.E.; Boykin, D.W.; Correia Soeiro, M.D. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro. Parasitology 2011,138(14),1863-1869","journal-title":"Parasitology"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"Pires D.E.","year":"2015","unstructured":"Pires D.E.; Blundell T.L.; Ascher D.B.; pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 2015,58(9),4066-4072","journal-title":"J Med Chem"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"e02205","DOI":"10.1128\/AAC.02205-17","volume":"62","author":"Santos C.C.","year":"2018","unstructured":"Santos C.C.; Lionel J.R.; Peres R.B.; Batista M.M.; da Silva P.B.; de Oliveira G.M.; da Silva C.F.; Batista D.G.J.; Souza S.M.O.; Andrade C.H.; Neves B.J.; Braga R.C.; Patrick D.A.; Bakunova S.M.; Tidwell R.R.; Soeiro M.N.C.; \n                        In vitro, in silico and in vivo analysis of novel aromatic amidines against Trypanosoma cruzi. Antimicrob Agents Chemother 2018,62(2),e02205-e02217","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1021\/ci400250c","volume":"53","author":"An Y.","year":"2013","unstructured":"An Y.; Sherman W.; Dixon S.L.; Kernel-based partial least squares: application to fingerprint-based QSAR with model visualization. J Chem Inf Model 2013,53(9),2312-2321","journal-title":"J Chem Inf Model"},{"key":"ref=252","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01936-17","author":"Nefertiti A.S.G.","unstructured":"Nefertiti A.S.G.; Batista M.M.; Da Silva P.B.; Batista D.G.J.; Da Silva C.F.; Peres R.B.; Torres-Santos E.C.; Cunha-Junior E.F.; Holt E.; Boykin D.W.; Brun R.; Wenzler T.; Soeiro M.N.C.; The trypanocidal effect of novel quinolines: In vitro and in vivo studies. Antimicrob Agents Chemother in Press","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ejmech.2017.12.052","volume":"144","author":"Lara L.S.","year":"2018","unstructured":"Lara L.S.; Moreira C.S.; Calvet C.M.; Lechuga G.C.; Souza R.S.; Bourguignon S.C.; Ferreira V.F.; Rocha D.; Pereira M.C.S.; Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: identification of a promising hit compound. Eur J Med Chem 2018,144,572-581","journal-title":"Eur J Med Chem"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"Cheng F.","year":"2012","unstructured":"Cheng F.; Li W.; Zhou Y.; Shen J.; Wu Z.; Liu G.; Lee P.W.; Tang Y.; admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 2012,52(11),3099-3105","journal-title":"J Chem Inf Model"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10822-016-9903-6","volume":"30","author":"Alberca L.N.","year":"2016","unstructured":"Alberca L.N.; Sbaraglini M.L.; Balcazar D.; Fraccaroli L.; Carrillo C.; Medeiros A.; Benitez D.; Comini M.; Talevi A.; Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning. J Comput Aided Mol Des 2016,30(4),305-321","journal-title":"J Comput Aided Mol Des"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","volume":"39","author":"Knox C.","year":"2011","unstructured":"Knox C.; Law V.; Jewison T.; Liu P.; Ly S.; Frolkis A.; Pon A.; Banco K.; Mak C.; Neveu V.; Djoumbou Y.; Eisner R.; Guo A.C.; Wishart D.S.; DrugBank 3.0: a comprehensive resource for \u2018omics\u2019 research on drugs. Nucleic Acids Res 2011,39(Database issue),D1035-D1041","journal-title":"Nucleic Acids Res"},{"key":"ref=257","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079568","volume":"8","author":"Novick P.A.","year":"2013","unstructured":"Novick P.A.; Ortiz O.F.; Poelman J.; Abdulhay A.Y.; Pande V.S.; SWEETLEAD: an in silico database of approved drugs, regulated chemicals, and herbal isolates for computer-aided drug discovery. PLoS One 2013,8(11)","journal-title":"PLoS One"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T11:24:05Z","timestamp":1585394645000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173418\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":257,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3,16]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190711121418","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}